NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/09/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization42.46 mln
Float13.87 mln
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.35
Low leverage
ROE
-43.20
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Genenta Science is an Italian biotech company founded in 2014 and based in Milan, focused on using modified stem cells to fight solid tumors. Its main therapy, Temferon, is currently in early-phase clinical trials as a treatment for an aggressive form of brain cancer and is also being explored for liver cancers. The company's broader research centers on a platform designed to deliver cancer-fighting molecules directly into tumors through the body's own immune cells.
